Please use this identifier to cite or link to this item:
Title: Cofilin immunolabelling correlates with depth of invasion in gastrointestinal endocrine cell tumors
Authors: Yan, B.
Wang, S.
Lee, C.K.
Salto-Tellez, M. 
Kumarasinghe, M.P. 
Yap, C.T. 
Koh, S.
Omar, M.F. 
Keywords: Cofilin
Gastrointestinal endocrine cell tumor
Issue Date: 2010
Citation: Yan, B., Wang, S., Lee, C.K., Salto-Tellez, M., Kumarasinghe, M.P., Yap, C.T., Koh, S., Omar, M.F. (2010). Cofilin immunolabelling correlates with depth of invasion in gastrointestinal endocrine cell tumors. Acta Histochemica 112 (1) : 101-106. ScholarBank@NUS Repository.
Abstract: Gastrointestinal endocrine cell tumors are a heterogeneous population of lesions believed to arise from neuroendocrine cells of the gastrointestinal mucosa. The current classification of these tumors is based on tumor size, microscopic features and clinical evidence of metastasis. Although diagnostic categories generally correlate with prognosis, molecular prognostic markers will be clinically useful adjuncts. Cofilin has been implicated in tumor invasion, and its immunolocalisation was studied in gastrointestinal endocrine cell tumors. The immunolocalisation of cofilin was studied by immunohistochemistry in 34 formalin-fixed, paraffin wax-embedded gastrointestinal endocrine cell tumors using a tissue microarray platform. A significant correlation was found between high cofilin immunolabelling and the depth of invasion (p<0.05). Our findings suggest that cofilin might be useful clinically as a molecular prognostic adjunct in the evaluation of gastrointestinal endocrine cell tumors. © 2008 Elsevier GmbH. All rights reserved.
Source Title: Acta Histochemica
ISSN: 00651281
DOI: 10.1016/j.acthis.2008.07.007
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.


checked on Jun 24, 2022


checked on Jun 24, 2022

Page view(s)

checked on Jun 23, 2022

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.